Lipocine Announced Topline Results From A Pilot Clinical PK Bridge Study Of LPCN 1154 (Oral Brexanolone) With A Comparator, Iv Brexanolone, Demonstrating LPCN 1154 Treatment Was Well-tolerated With No Hypoxia Or Sedation-related Adverse Events
Benzinga Newsdesk - May 16, 2023, 7:15AM